A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors

NCT01755390 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi